Azathioprine, a widely used immunosuppressant, is also used in the control of inflammatory disorders. These are characterized by the local accumulation of immune effector cells that produce reactive oxygen species (ROS). The DNA of azathioprine-treated patients contains 6-thioguanine (6-TG), a base analogue that is particularly susceptible to oxidation. Here, we show that 6-TG is vulnerable to ROS produced by chemical oxidants and that cells containing DNA 6-TG are hypersensitive to these oxidants. We also show that 6-TG incorporated into the DNA of macrophages sensitizes them to killing by endogenously produced ROS. ROS generated by macrophages are also a hazard for cocultured nonmacrophage cells containing DNA 6-TG. This bystander vulnerability of cells containing DNA 6-TG to oxidation by ROS generated by immune effector cells has implications for the long-term use of azathioprine in the management of inflammatory disorders. [Cancer Res 2009;69(6):2393-9] 
Introduction
Chronic inflammatory disorders are relapsing and remitting conditions that reflect an underlying immune dysfunction. Chronic inflammation can be a risk factor for the development of malignancy, and patients with ulcerative colitis and Crohn's disease have an increased risk of colonic epithelial dysplasia and carcinoma (1) . Current treatments for this group of diseases involve nonspecific suppression of the inflammatory processes with drugs, such as nonsteroidal anti-inflammatory drugs and steroids, antibiotics, and modulators of the immune response. In the latter category, the thiopurines azathioprine and 6-mercaptopurine (6-MP) are the treatments of choice for severe inflammatory bowel disease (IBD) and are often used in the management of rheumatoid arthritis (2) . Thiopurines are efficacious and 70% of patients with steroid-dependent IBD achieve and maintain remission (3) . Azathioprine is a prodrug that is cleaved to 6-MP, which in turn is metabolized to 6-thioguanine (6-TG) nucleotides (TGN). These are precursors of DNA synthesis and 6-TG becomes incorporated into DNA of patients taking azathioprine (4, 5) . DNA 6-TG has two properties that distinguish it from the canonical DNA bases. Firstly, it is a UVA chromophore with an absorbance maximum at 340 nm and is photochemically susceptible to UVA. One of the photoproducts of DNA 6-TG, guanine-6-sulfonate (G SO3 ), is a strong block to replication in vitro and in vivo. This lesion can, however, be bypassed by error-prone DNA polymerases (6) in an emergency response that is a potential source of mutation (7, 8) . The corresponding photochemical reactions occur in patients taking azathioprine whose skin contains DNA 6-TG and is selectively sensitive to UVA wavelengths (9) . The second important feature of DNA 6-TG is its low oxidation potential. The formation of G SO3 reflects the relatively favorable oxidation of 6-TG by reactive oxygen species (ROS) generated photochemically by UVA.
Oxygen-related DNA damage is an inescapable hazard and cells have evolved multiple protective and repair systems to minimize the detrimental consequences of oxidized DNA, which include disease and aging. ROS are important signaling molecules and their intracellular levels are normally under careful control (10) . Excessive production of ROS, following, for example, exposure to oxidizing chemicals such as H 2 O 2 , causes oxidative stress and DNA damage. Persistent oxidative DNA damage is linked to human cancer (11) . Chronic inflammatory disorders are characterized by the infiltration of a large numbers of neutrophils, monocytes, and lymphocytes into the affected sites (see ref. 12 for review). These immune effector cells are a significant source of ROS and they generate H 2 O 2 and superoxide (O 2 ÁÀ ) as part of their defense against pathogens. The persistence of inflammatory cells and the associated production of ROS are thought to play an important role in the pathogenesis of IBD. In addition, the duration and severity of inflammation are risk factors in the development of colon cancer in IBD patients (13, 14) .
Systemic treatment with thiopurines introduces 6-TG into the DNA of all dividing cells, and we were interested to examine whether cells containing DNA 6-TG might be particularly at risk from ROS produced by immune effector cells. Here, we show that 6-TG is highly susceptible to oxidation by H 2 O 2 , one of the main components of ROS generated by immune cells, and to KBrO 3 , another chemical oxidant, and that cells containing DNA 6-TG are hypersensitive to killing by these oxidants. To mimic the infiltration of ROS-generating cells into sites of chronic inflammation, target cells containing DNA 6-TG were cocultured with an established macrophage cell line. Our results show that ROS produced by macrophages oxidizes the DNA 6-TG of cocultured target cells and that this results in increased target cell death.
Materials and Methods
Unless stated, all chemicals were obtained from Sigma-Aldrich. Cell culture. HCT116 human colon carcinoma, SV40-transformed GM04429f and MRC5-VA human fibroblast, and the murine macrophage precursor J774a.1 cell lines obtained from the Cancer Research UK, London Research Institute, Central Cell Services were grown in DMEM supplemented with 10% FCS (Life Technologies/Invitrogen). CCRF-CEM leukemia cells were grown in suspension culture in RPMI 1640 supplemented with 10% FCS. HCT116, GM04429f, and MRC5-VA cells were maintained in 10% CO 2 , whereas the CCRF-CEM and J774a.1 cells were maintained at 5% CO 2 in 37jC humidified incubators.
Thioguanine labeling and oxidant treatment. Cells were routinely cultured for 48 h in medium containing 0.5 or 1 Amol/L of 6-TG. Intracellular ROS production by lipopolysaccharide (LPS)-stimulated (10 Ag/mL; Sigma-Aldrich) macrophages was examined by light microscopy. J774a.1 cells were incubated with 5 Amol/L CM-H2DCFDA for 20 min at 37jC, washed with PBS, and examined for green fluorescence by microscopy [Zeiss Axioplan fitted with Hamamatsu C4747-95 digital camera; images were acquired using OpenLab v2.2.5 (Improvision)].
ROS released by J774a.1 cells were quantitated by microassay (15) . For H 2 O 2 , 100 AL of assay solution (28 mmol/L phenol red, 100 units/mL horseradish peroxidase in HBSS) were added to LPS-stimulated (1-10 Ag/mL) J774a.1 cells in 96-well plates. After incubation for 1 h at 37jC, the reaction was stopped by the addition of 10 AL 1N NaOH and A 630 nm was determined.
For O 2
À
, LPS-stimulated cells in 100 AL of assay solution (160 Amol/L cytochrome c made fresh in HBSS) were incubated at 37jC for 1 h. The reaction was stopped by the addition of 10 AL superoxide dismutase (3,000 units/mL) and A 550 nm was determined.
DNA synthesis. Cells were grown in medium containing 6-TG for 24 h, washed, and resuspended in PBS before treatment with H 2 O 2 for 1 h. After treatment, cells were returned to fresh medium and pulse labeled with [5 ¶-3 H]thymidine (1 ACi/mL; 511 GBq/mmol) for 15 min at 37jC. Trichloroacetic acid (TCA)-insoluble radioactivity in 2 Â 10 6 cells was determined by scintillation counting. All experiments were performed in duplicate.
6-TG incorporation. Cells were treated with 6-TG for 48 h and washed with PBS, and DNA was extracted using the Wizard Genomic DNA Purification kit (Promega UK) according to the manufacturers' instructions. DNA (100 Ag in 100 AL total volume) was digested to nucleosides with 10 units of nuclease P1 (1 h, 50jC) followed by 2 units of alkaline phosphatase (1 h, 37jC). Deoxynucleosides were separated by highperformance liquid chromatography (HPLC) as described (7) using a Waters Symmetry C18 column equipped with a Waters 2487 Dual Wavelength Absorbance detector and a Waters 2475 Multiwavelength Fluorescence detector. Elution was with a gradient of 10 mmol/L KH 2 PO 4 (pH 6.7) in methanol. Column eluates were monitored simultaneously by A 342 and fluorescence at 410 nm. 6-TG substitution was calculated as a percentage of total deoxyguanosine in the same samples. Guanine sulfonate was detected by its fluorescence and quantitated by comparison with an authentic standard. Calibration curves for guanine sulfonate were linear up to 10 nmol and the detection limit was f50 fmol.
Results
Susceptibility of 6-TG to chemical oxidation. In view of the susceptibility of 6-TG to photooxidation by UVA (7), we examined its chemical oxidation. The deoxyribonucleoside of 6-TG (6-TGdR) was treated with H 2 O 2 and the products were analyzed by reversephase HPLC. The 6-TGdR was monitored by its absorbance at 342 nm. Figure 1A shows that treatment with H 2 O 2 destroyed the 6-TGdR as indicated by the loss of A 342 . The single detectable product was fluorescent (excitation k max , 324 nm; emission k max , 410 nm). This property, together with its elution time (Fig. 1B) (Fig. 1C) . We conclude that 6-TG is susceptible to chemical oxidation to G SO3 , a known product of photochemical oxidation.
DNA 6-TG sensitizes cells to chemical oxidants. HCT116 colorectal carcinoma cells were used to examine whether DNA 6-TG influenced sensitivity to the cytotoxic effects of chemical oxidants. These DNA mismatch repair-defective cells incorporate significant levels of DNA 6-TG without detectable toxicity. Following growth for 24 hours in the presence of 1 Amol/L 6-TG, f0.25% of the total DNA guanine was replaced by 6-TG. The 6-TGtreated cells were then exposed to H 2 O 2 , KBrO 3 , or IR and their clonal survival was compared with that of similarly treated cells without DNA 6-TG. Figure 2A shows that DNA 6-TG caused a significant sensitization to H 2 O 2 . Formation of intracellular ROS was confirmed using CM-H2DCFDA, a dye that emits green fluorescence on reaction with ROS ( Fig. 2A, inset) . 6-TG-treated HCT116 cells were also more sensitive to KBrO 3 ( Fig. 2B) , which also generated measurable levels of intracellular ROS (Fig. 2B,  inset) . In contrast, the presence of DNA 6-TG did not significantly alter the sensitivity of cells to IR (Fig. 2C ) under conditions that did not detectably increase steady-state levels of ROS (Fig. 2C, inset) . We conclude that DNA 6-TG sensitizes cells to treatments that generate ROS. It is likely that the susceptibility of DNA 6-TG to oxidation underlies this effect.
The UVA photoproducts of DNA 6-TG, particularly DNA G SO3 , are robust inhibitors of DNA replication (8) . In agreement with the likely formation of DNA G SO3 , H 2 O 2 induced a pronounced replication inhibition in HCT116 cells containing DNA 6-TG (Fig. 2D) . These data are consistent with the oxidation of DNA 6-TG to replication-blocking DNA lesions, including G SO3 , and the enhanced sensitivity of 6-TG-treated cells to killing by oxidizing chemicals.
Lethal oxidation products are not excised by nucleotide excision repair. Nucleotide excision repair (NER) can excise potentially lethal lesions, which distort the DNA double helix (16) . To investigate whether NER could ameliorate the lethal effects of oxidized DNA 6-TG, we compared the sensitivity of cell lines proficient or defective in NER. GM04429f cells, SV40-transformed fibroblasts derived from a xeroderma pigmentosum (XP) group A patient, and MRC5-VA, similarly transformed fibroblasts from a clinically normal individual, were cultured for 48 hours in 0.5 Amol/L 6-TG. This resulted in comparable levels of DNA substitution by 6-TG (0.22% DNA guanine in GM04429f and 0.26% in MRC5-VA). The presence of this relatively low level of DNA 6-TG did not detectably affect the viability of either cell line as determined by clonogenic assay (data not shown). Cells were treated with H 2 O 2 and clonal survival was measured. In agreement with published findings (17), GM04429f cells were f2-fold more sensitive than MRC5-VA to H 2 O 2 (Fig. 3) . DNA substitution by 6-TG sensitized GM04429f cells to H 2 O 2 and induced a similar degree of sensitization in MRC5-VA cells. The intrinsic hypersensitivity to UVC of GM04429f cells was confirmed in a parallel experiment in which cells not treated with 6-TG were exposed to UVC (Fig. 3, inset) . Similar results were obtained with a second XPA cell line, XP12RO, in which DNA 6-TG induced a similar degree of sensitization to H 2 O 2 (data not shown). These findings indicate that NER does not play a significant role in the removal of potentially cytotoxic DNA lesions produced by the chemical oxidation of DNA 6-TG.
DNA 6-TG oxidation by ROS from immune effector cells. As a model for ROS-secreting immune effector cells in an intense inflammatory microenvironment, we used the murine macrophage precursor cell line J774a.1. Microassays (15) Fig. 4A and B) . ROS generation by J774a.1 cells was confirmed by fluorescent microscopy using CM-H2DCFDA dye. Within 1 hour of treatment with LPS, there was an f10-fold increase in the number of positively staining cells. Even after stimulation, however, only f10% of cells contained detectable ROS; a representative image is presented in Fig. 4C . The percentage of positive cells remained approximately constant for up to 48 hours after stimulation (Fig. 4D) , although direct microscopic examination indicated that the secreting cell population changed with time, possibly indicating paracrine signaling. Overall, it was apparent that the high levels of ROS are maintained for at least 48 hours after LPS stimulation.
To examine whether DNA was vulnerable to oxidation by endogenous ROS, we compared DNA 6-TG oxidation in J774a.1 and HCT116 cells. Cells were cultured in the presence of 6-TG for 48 hours, DNA was extracted, and the extent of DNA substitution by 6-TG and the fraction of incorporated 6-TG that had been oxidized to G SO3 was determined by HPLC. In the ROS-producing J774a.1 cells, 0.4 F 0.16% of incorporated 6-TG had been converted to DNA G SO3 . This value is 5-fold higher than the 0.08 F 0.05% DNA G SO3 associated with a similar level of 6-TG substitution in HCT116 cells. The increased ROS production that accompanied LPS treatment doubled the extent of DNA 6-TG oxidation in J774a.1 cells and G
SO3
comprised 0.85% of incorporated 6-TG in stimulated cells (Fig. 5A) . ROS produced by immune effector cells are released into the surrounding tissue. We examined whether DNA 6-TG in neighboring cells might also be susceptible to secreted ROS. To do this, we cocultured J774a.1 cells with CCRF-CEM leukemic cells, which grow in suspension and can be easily separated from the tenaciously adherent macrophages. CCRF-CEM cells treated for 48 hours with 6-TG to replace 2% to 2.5% of their DNA guanine were mixed with LPS-activated J774a.1 cells and cocultured for a further 48 hours. At the end of this period, nonadherent cells were recovered and their DNA was analyzed for 6-TG and G SO3 . Figure  5B shows that in the absence of J774a.1 cells, 0.03% of the DNA 6-TG was present as G SO3 . Following culture with activated J774a.1 cells, this value increased to 0.22%.
Cytotoxicity of ROS from immune effector cells. The accumulation of a high level of DNA G SO3 was associated with a loss of cell viability. Annexin V and PI staining and FACS analysis of J774a.1 cells that had incorporated 6-TG during 48-hour incubation revealed a 6-TG dose-dependent loss of viability over the subsequent 48-hour period (Fig. 6) . LPS treatment to increase the amount of DNA G SO3 significantly enhanced the cytotoxicity (Fig. 5C) . In contrast, the 5-fold lower level of DNA G SO3 in HCT116 was not associated with cell death and treatment of these cells with LPS did not affect cell viability. We conclude that DNA 6-TG in J774a.1 cells renders them vulnerable to their constitutively high levels of ROS, and in this model macrophage, spontaneous oxidation of DNA 6-TG contributes to the cytotoxicity of 6-TG treatment. This toxic hazard is exacerbated by the increased ROS production that follows LPS activation.
To investigate the cytotoxic effects of ROS generated by immune effector cells on adjacent cells in trans, 6-TG-treated HCT116 cells were cocultured with J774a.1 macrophages. HCT116 cells with or without DNA 6-TG were plated together with J774a.1. After coculture for 48 hours, all the cells were recovered and the viability of target HCT116 cells was assessed by FACS analysis with Annexin V and PI staining. Figure 6A shows a representative dot plot of 6-TG-treated HCT116 cells. Negative staining for Annexin V and PI confirms that the majority of these cells were viable. Coculture with J774a.1 reduced the viability of HCT116 cells as indicated by the increased fraction of PI-positive and/or Annexin V-positive cells (Fig. 6B ). After coculture with J774a.1 cells, HCT116 cells were gated using forward and side scatter to exclude the larger and more granular J774a.1 cells from the analysis (Fig. 6B, inset) . There was a small but reproducible reduction of f20% in HCT116 viability in the presence of unstimulated J774a.1 cells and this was significantly augmented to >60% by prior activation with LPS. Figure 6C summarizes data from four independent experiments. Qualitatively similar results were obtained with 6-TG-treated CCRF-CEM cells as the target. LPS-activated J774a.1 cells reduced viability by 50% (Fig. 6C) . À microassay based on the reduction of cytochrome c. C, cells were loaded with the ROS-reactive dye CM-H2DCFDA before activation with LPS (100 Ag/mL) and analyzed by fluorescent microscopy 24 h later. Following LPS activation, macrophages differentiated to produce a varied cell morphology, which included several large and very granular cells (arrow ). Fluorescent staining for ROS reflected this variation in morphology and cells displaying punctated cytoplasmic staining as well as whole-cell staining were observed. Scale bar, 50 Am. The fraction of ROS-positive cells (D ) includes all these predominant staining patterns. Protection by antioxidants. Antioxidants protected DNA 6-TG-containing target cells against oxidation of their DNA and against the cytotoxic effect of oxidation products. The formation of DNA G SO3 in CCRF-CEM cells cocultured with LPS-activated J774a.1 cells was largely (80%) prevented by pretreatment with N-acetylcysteine (NAC), an acknowledged ROS scavenger (Fig. 6D) . This protective effect was accompanied by a significant increase in cell survival and the viability of cocultured HCT116 and CCRF-CEM cells was almost doubled by NAC treatment (Fig. 6C) . These observations provide confirmation of the involvement of ROS in the oxidation of DNA 6-TG and the contribution of oxidized DNA 6-TG lesions to cell death.
We conclude that cells containing DNA 6-TG are particularly vulnerable to killing by ROS produced from activated immune effector cells. This hypersensitivity affects the effector cells themselves as well as closely adjacent cells. Reduced viability is correlated with the susceptibility of DNA 6-TG to oxidation.
Discussion
The cytotoxicity of 6-MP and its parent compound azathioprine is partly mediated by metabolism into TGNs (18, 19) . Systemic 6-MP or azathioprine treatment causes 6-TG to accumulate in the DNA of proliferating cells and DNA 6-TG is detectable in patients' lymphocytes (4, 5) and skin (7). 6-TG is more reactive than canonical DNA bases (20) , and we are interested in the implications of this reactivity for the welfare of patients undergoing long-term thiopurine therapy. DNA 6-TG is cytotoxic via its interaction with DNA mismatch repair (reviewed in ref. 19 ). The effects of DNA 6-TG we report here were independent of mismatch repair status, however, and were similar in repair-deficient HCT116 and CCRF-CEM cells and repair-proficient MRC5-VA fibroblasts, two XPA fibroblast lines, and J774a.1 macrophages. Our findings reveal a new mechanism by which DNA 6-TG is hazardous to cells. Its susceptibility to ROS produced in a biological context has implications for its use as an anti-inflammatory agent.
Although DNA 6-TG levels in patients undergoing thiopurine therapy are lower than those in our cultured cells (7), they nevertheless have detectable consequences; the skin of azathioprine-treated patients is selectively hypersensitive to UVA (9) . Systemic azathioprine or 6-MP treatment often continues for many months or years, entailing a concomitant risk of more subtle chronic effects. The acute UVA sensitivity of azathioprine patients' skin reflects the relatively favorable oxidation of DNA 6-TG by photochemically generated ROS. Our present findings extend this observation and show a susceptibility to chemical oxidants H 2 O 2 and KBrO 3 , both of which increase the steady-state levels of intracellular ROS. Cell death was predominantly by necrosis and both agents induced rapid replication arrest. All these observations are consistent with oxidation of cellular DNA 6-TG to G SO3 , which is a powerful replication block (8) .
The fate of oxidized DNA 6-TG in cells is not yet established, although our findings indicate that G SO3 is removed poorly from DNA, and these and other potentially harmful oxidative DNA lesions are likely to remain in the affected cells throughout their lifetime. Oxidation products of DNA 6-TG, including DNA G SO3 , are essentially iatrogenic DNA lesions of recent origin, and it seems unlikely that specific DNA damage/repair responses have evolved to process them. G SO3 is bulky, causes significant destabilization of duplex DNA (8) , and is therefore a potential substrate for excision by NER. DNA 6-TG produced a similar degree of sensitization to H 2 O 2 in NER-proficient cells and XPA cells, however. Although these findings do not directly address the fate of DNA G SO3 , they do indicate that NER does not efficiently excise potentially lethal oxidized 6-TG DNA adducts. Preliminary data 1 confirm that DNA G SO3 formed by UVA radiation is highly persistent. Figure 5 . Oxidation of J774a.1 DNA 6-TG by endogenous ROS and sensitization to killing. A, HCT116 or J774a.1 cells were grown for 48 h in the presence or absence of LPS (100 Ag/mL) and 6-TG (1 Amol/L, HCT116; 0.5 Amol/L, J774a.1). DNA was extracted, digested to deoxynucleosides, and separated by HPLC. 6-TGdR and G SO3 dR were quantified by A 342 and by fluorescence. In HCT116 cells, 6-TG replaced 0.42% DNA G. For J774a.1 cells, this value was 0.7%. Data are expressed as the percentage conversion from 6-TG to G SO3 dR. Inset, ROS levels of HCT116 (light gray ) or J774a.1 cells (dark gray ) containing 6-TG used for the measurement of 6-TG:G SO3 described above were assessed by CM-H2DCFDA staining and FACS. B, 6-TG-treated CCRF-CEM cells (48 h, 1 Amol/L) were coincubated for further 48 h with LPS-activated (100 Ag/mL) J774a.1 cells. DNA from nonadherent cells was extracted, digested to deoxynucleosides, separated by HPLC, and quantified as above. C, HCT116 and J774a.1 cells were grown in the presence of 6-TG (as shown) for 48 h and either left untreated (black columns) or treated with LPS (100 Ag/mL; gray columns ) for a further 48 h. Cell viability was determined by Annexin V/PI staining and FACS analysis. Columns, mean of three independent experiments; bars, SD.
One important finding is that cells containing DNA 6-TG are also sensitive to biologically derived ROS of which immune effector cells are an acknowledged source. Sites of chronic inflammation are associated with sustained generation of ROS from the respiratory burst of infiltrating activated neutrophils and monocytes (21, 22) . Macrophages are postmitotic in vivo. Their differentiation in the presence of 6-TG would, however, lead to its incorporation during the proliferative phase of their maturation. Our findings indicate that macrophages that contain DNA 6-TG are at risk from selfinflicted DNA 6-TG oxidation and their sustained high level of endogenous ROS swiftly leads to cell death. Our coculture experiments indicate a second potential threat of biological ROS: cells in the vicinity of activated macrophages are also at risk of DNA damage. These bystander cells also accumulated a significant burden of cytotoxic DNA G SO3 in a reaction that was prevented by free radical scavengers.
Azathioprine and 6-MP are effective immunomodulatory therapies for active IBD (23) . Chronic inflammation is a predominant contributor to the development of epithelial cancers and IBD patients have an increased risk of bowel cancer (14, 24, 25) . There is some evidence to suggest that azathioprine may reduce cancer risk (14) , although other studies have revealed no significant effect (24) (25) (26) . It is possible that the selective suicide of activated immune effector cells containing DNA 6-TG contributes to the reduction in inflammation and reduces the risk of malignancy. This protective effect may be partially offset by the consequences of accumulated irreparable DNA lesions in bystanders in the vicinity of ROSproducing cells. 6-MP is used in remission maintenance regimens for leukemia. We note that because rapidly dividing tumor cells will incorporate relatively high levels of DNA 6-TG, they may have enhanced susceptibility to killing by drugs that generate ROS. The possibility that 6-TG combination therapy with this type of agent might provide a synergistic anticancer benefit suggests a potential new therapeutic role for this long-established class of drugs.
In summary, cells containing DNA 6-TG are susceptible to killing by chemical oxidants. Replication-blocking, potentially lethal oxidized DNA 6-TG lesions are not excised by NER and accumulate in cellular DNA. In an in vitro macrophage cell model, sustained release of H 2 O 2 and O 2 À is associated with rapid and fatal accumulation of DNA G SO3 . DNA 6-TG-containing target cells cocultured with macrophages were also vulnerable to DNA oxidation and killing. In as far as this simple model mimics chronic inflammation of the gut during IBD and treatment with thiopurines, the findings suggest that the low oxidation potential of DNA 6-TG may influence the immunomodulatory effects of thiopurines and the possible long-term effects of such treatment.
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